XML 80 R62.htm IDEA: XBRL DOCUMENT v3.25.1
Debt (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jan. 01, 2025
Nov. 22, 2024
Mar. 21, 2023
Dec. 31, 2024
Dec. 31, 2023
Mar. 13, 2023
Short-Term Debt [Line Items]            
Principal amount       $ 21,975 $ 11,019  
Debt instrument maturity date     Mar. 21, 2025      
Gross proceeds       21,615 10,000  
Principal repayments     $ 292      
Debt extinguishment losses       5,167 26  
Repayment of senior convertible note       $ 3,616  
Interest rate percentage       18.00%    
March 2023 Senior Convertible Note [Member]            
Short-Term Debt [Line Items]            
Principal amount     $ 11,100   $ 11,019 $ 11,100
Interest rate, percentage     7.875%   7.875%  
Conversion price     $ 5.00   $ 5.00  
Debt instrument maturity date     Mar. 21, 2025   Mar. 21, 2025  
Gross proceeds     $ 9,925      
Lender fee and offering costs     $ 1,186      
Interest Expense, Debt         $ 391  
Principal repayments       $ 8,365    
Financial payment term description     (i) a minimum of $5.0 million of available cash at all times; (ii) the ratio of (a) the outstanding principal amount of the total senior convertible notes outstanding, accrued and unpaid interest thereon and accrued and unpaid late charges to (b) the Company’s average market capitalization over the prior ten trading days, as of the last day of any fiscal quarter commencing with September 30, 2023, to not exceed 30%; and (iii) the Company’s market capitalization to at no time be less than $30 million.      
Payment term description     The March 2023 Senior Convertible Note installment payments were payable in shares of Lucid Diagnostics common stock at a conversion price that was the lower of the contractual conversion price and 82.5% of the two lowest VWAPs during the last 10 trading days preceding the date of conversion, subject to a conversion price floor of $0.30. The notes are also subject to certain provisions that may require redemption upon the occurrence of an event of default, a change of control, or certain equity issuances.      
Interest expense       $ 912    
Debt conversion, shares issued       13,866,867    
Debt conversion, fair value of shares issued       $ 13,482    
Debt extinguishment losses       4,205    
Repayment of senior convertible note       3,616    
Extinguishment loss       962    
2024 Convertible Notes [Member]            
Short-Term Debt [Line Items]            
Principal amount   $ 21,975   $ 21,975    
Interest rate, percentage   12.00%   12.00%    
Conversion price   $ 1.00   $ 1.00    
Debt instrument maturity date       Nov. 22, 2029    
Gross proceeds   $ 21,975        
Net proceeds   $ 18,300        
Subscription receivable       $ 400    
Debt term   5 years        
Convertible notes description   the Company is subject to certain customary affirmative and negative covenants regarding the incurrence of indebtedness, the existence of liens, the repayment of indebtedness and the making of investments, the payment of cash in respect of dividends, distributions or redemptions, the transfer of assets, the maturity of other indebtedness, transactions with affiliates, and the consummation of fundamental transactions where the aggregate consideration payable in respect thereof, as determined on a per share of the Company’s common stock basis, has a fair market value that is less than $1.50, among other customary matters. Under the 2024 Convertible Notes, the Company is subject to a financial covenant requiring that the amount of its available cash equal or exceed $5.0 million at all times that at least 25% of the principal amount of 2024 Convertible Notes issued are outstanding.        
2024 Convertible Notes [Member] | Common Stock [Member]            
Short-Term Debt [Line Items]            
Weighted average price of common stock   $ 10.00        
2024 Convertible Notes [Member] | Subsequent Event [Member]            
Short-Term Debt [Line Items]            
Subscription received $ 400